ReviewCurrent neuropharmacology2016

Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review.

Francesco Matrisciano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.